ACIP recs for novel H1N1 vaccine

The ACIP recommendations for who should get priority to receive the novel H1N1 vaccination includes 50% of the US population: Young persons age 6mo – 24 years, household contacts of those <6 mo, pregnant women, healthcare workers, and adults age 25-64 with underlying risk conditions (such as immunosuppression or other chronic diseases such as diabetes / chronic lung disease) (website)

Danielle Scheurer

Dr. Scheurer is a clinical hospitalist and the Medical Director of Quality and Safety at the Medical University of South Carolina in Charleston, South Carolina, and is Assistant Professor of Medicine. She is a graduate of the University of Tennessee College of Medicine, completed her residency at Duke University, and completed her Masters in Clinical Research at the Medical University of South Carolina. She also serves as the Web Editor and Physician Advisor for the Society of Hospital Medicine.

Leave a Comment